US2003064940A1PendingUtilityA1

Kit for treating acne vulgaris using avermectin compound

Priority: Oct 2, 2001Filed: Jun 3, 2002Published: Apr 3, 2003
Est. expiryOct 2, 2021(expired)· nominal 20-yr term from priority
Inventors:L. Dean Parks
A61K 31/704A61Q 19/10A61K 8/498
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A kit for treating acne vulgaris are disclosed. The treatment includes topical application of a dermatological composition containing an avermectin compound to the affected areas of a patient alone, or in conjunction with other conventional methods of treating acne vulgaris. The dermatological composition of the kit contains an avermectin compound in a pharmaceutically acceptable carrier, including water, glycols, alcohols, lotions, creams, gels, emulsions, sprays, soaps, body washes, facial cleansers, and facial masks.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A kit for treating acne vulgaris comprising: 
 (a) a dermatological composition in a container, said dermatological composition comprising therapeutically effective amount of avermectin compound and a pharmaceutically acceptable carrier, and    (b) instructions on, or associated with, said container regarding how to use said dermatological composition for treating acne vulgaris.    
     
     
         2 . The kit of  claim 1 , wherein said avermectin compound comprises: 
 avermectins, avermectin derivatives, ivermectin, or ivermectin derivatives.    
     
     
         3 . The kit of  claim 2  in said carrier comprises: 
 water, glycols, alcohols, lotions, creams, gels, emulsions, sprays, soaps, body washes, facial cleanser, and facial masks.  
 
     
     
         4 . The kit as recited in  claim 1 , further comprising: 
 a therapeutically effective amount of at least one other anti-acne medication.    
     
     
         5 . The kit as recited in  claim 4 , in which said at least one other anti-acne medication comprises benzoyl peroxide, sulfur, resorcinol, salicyclic acid, opioid, tretinoin, antibiotics, and isotretinoin.  
     
     
         6 . The kit as recited in  claim 2 , in which said avermectin compound is in a dermatological composition comprising said avermectin compound in a concentration greater than about 0.05%, and a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2003064940A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.